Qubiotech
Qubiotech develops Neurocloud, a cloud-based platform for automatic quantification of neuroimaging biomarkers to aid clinical diagnosis and monitoring of neurological diseases. Its AI-assisted software processes multimodal images (PET, SPECT, MRI) automatically, providing fast, reliable, and clinically validated results integrated with clinical workflows. Neurocloud supports neurology, radiology, nuclear medicine, and epileptology, enhancing diagnostic accuracy, early detection, and patient follow-up. The platform is CE marked and authorized by AEMPS, compatible with existing hospital technology, and offers continuous updates and personalized support. Qubiotech collaborates with leading hospitals and research groups, positioning itself as a key player in neuroimaging diagnostics with a scalable SaaS business model.
Qubiotech
Qubiotech develops Neurocloud, a cloud-based platform for automatic quantification of neuroimaging biomarkers to aid clinical diagnosis and monitoring of neurological diseases. Its AI-assisted software processes multimodal images (PET, SPECT, MRI) automatically, providing fast, reliable, and clinically validated results integrated with clinical workflows. Neurocloud supports neurology, radiology, nuclear medicine, and epileptology, enhancing diagnostic accuracy, early detection, and patient follow-up. The platform is CE marked and authorized by AEMPS, compatible with existing hospital technology, and offers continuous updates and personalized support. Qubiotech collaborates with leading hospitals and research groups, positioning itself as a key player in neuroimaging diagnostics with a scalable SaaS business model.